VCAM1 and neoplasm: Through the deregulation of ICAM-1 and vascular cell adhesion protein 1 (VCAM-1), VEGF-A can also lessen the adhesion between lymphocytes and tumor vascular endothelial cells, which in turn reduces TIL penetration [144].